Trial Profile
Phase II Trial of Intrahepatic Artery Chemotherapy With Nexavar [sorafenib] in Hepatocellular Carcinoma Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Carboplatin; Cisplatin
- Indications Liver cancer
- Focus Adverse reactions
- 04 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Apr 2009 New trial record